Cancer Discovery publishes high-impact articles featuring major advances in research and clinical trials. Topics span the spectrum of cancer research and medicine from the laboratory to the clinic to ...

Lung cancer is one of the deadliest forms of cancer, and for many patients, asbestos exposure may be to blame. You may be eligible for compensation if you've been diagnosed with lung cancer caused by ...

Metastatic cancer to the lungs means that cancer from another region of the body has spread to the lungs. Another term for metastatic cancer to the lungs is secondary cancer in the lungs, as the ...

The Alaska Watchman aims to raise awareness of key issues affecting Alaskans. Coming from a broadly Judeo-Christian perspective, we are committed to the highest standards of journalism and ethical ...

Atelectasis can be due to tumors growing in lung tissue or an airway. Cancer develops when cells in a person’s body begin to divide uncontrollably. These abnormal cells can form tumors and cause ...

Feb. 6, 2025 — Scientists have created a new low-cost, fast response sensor to detect lung cancer biomarkers, paving the way for the development of screening devices to spot the disease even ...

A recent breakthrough in lung cancer treatment has introduced a new kinase inhibitor, Lazertinib (Lazcluze®), specifically targeting patients with non-small cell lung cancer (NSCLC) who have common ...

Early diagnosis of lung cancer is a critical priority in clinical practice. It may help reduce the rate of lung-cancer-related mortality, extend disease-free survival, and allow patients to live ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Real-world lung cancer screening populations are older and sicker than those in the National Lung Screening Trial.

The Number of Grants for each Cancer Type may include grants not 100% focused on that type of cancer. For example, a grant that focuses 90% on breast cancer and 10% on prostate cancer will be counted ...

“We believe zongertinib has the potential to transform the care of previously treated patients with HER2 (ERBB2)-mutant advanced non-small cell lung cancer and are hopeful about the continued ...